Citing Affair, Petraeus Resigns as C.I.A. Director





WASHINGTON — David H. Petraeus, the director of the Central Intelligence Agency and one of America’s most decorated four-star generals, resigned on Friday after an F.B.I. investigation uncovered evidence that he was carrying on an extramarital affair.




Mr. Petraeus issued a statement acknowledging the affair after President Obama accepted his resignation and it was announced by the C.I.A. He had offered to resign on Thursday when he informed Mr. Obama about the affair, White House officials said.


Government officials said that the F.B.I. had investigated whether a computer used by Mr. Petraeus had been compromised. In the course of that inquiry, federal investigators discovered the relationship, officials said.


Senior members of Congress were alerted to Mr. Petraeus’s impending resignation by intelligence officials about six hours before the C.I.A. announced his resignation. One Congressional official who was briefed on the matter said that Mr. Petraeus had been encouraged “to get out in front of the issue” and resign, and that he agreed.


As for how the affair came to light, the Congressional official said that “it was portrayed to us that the F.B.I. was investigating something else and came upon him. My impression is that the F.B.I. stumbled across this.”


The official said they were not told the name of the woman or any other details about the F.B.I. investigation.


The F.B.I. did not inform the Senate and House Intelligence Committees about the investigation before this week, according to Congressional officials, who noted that by law the panels — and especially their chairmen and ranking members — are supposed to be told about significant developments in the intelligence arena. Senator Dianne Feinstein of California, the Democratic chairman of the committee, plans to pursue the question of why the committee was not told, one official said.


The revelation of a secret inquiry into the head of the nation’s premier spy agency raised urgent questions about Mr. Petraeus’s tenure and the decision by Mr. Obama to elevate him last year to head the C.I.A. after leading the country’s war effort in Afghanistan. White House officials said they did not know about the affair until this week, when Mr. Petraeus informed them.


“After being married for over 37 years, I showed extremely poor judgment by engaging in an extramarital affair,” Mr. Petraeus said in his statement, expressing regret for his abrupt departure. “Such behavior is unacceptable, both as a husband and as the leader of an organization such as ours. This afternoon, the president graciously accepted my resignation.”


Mr. Petraeus’s admission and resignation represent a remarkable fall from grace for one of the most prominent figures in America’s modern military and intelligence community, a commander who helped guide the nation’s wartime activities in the decade after the Sept. 11 attacks and was credited with turning around the failing war effort in Iraq.


Mr. Petraeus almost single-handedly forced a profound evolution in the country’s military thinking and doctrine with his philosophy of counterinsurgency, focused more on protecting the civilian population than on killing enemies. More than most of his flag officer peers, he understood how to navigate Washington politics and media, helping him rise through the ranks and obtain resources he needed, although fellow Army leaders often resented what they saw as a grasping careerism.


“To an important degree, a generation of officers tried to pattern themselves after Petraeus,” said Stephen Biddle, a military scholar at George Washington University who advised Mr. Petraeus at times. “He was controversial; a lot of people didn’t like him. But everybody looked at him as the model of what a modern general was to be.”


White House officials say they were informed on Wednesday night that Mr. Petraeus was considering resigning because of an extramarital affair. Intelligence officials notified the president’s national security staff. Mr. Obama was at the time on his way back to Washington from Chicago, where he had gone to receive Tuesday’s election returns.


This article has been revised to reflect the following correction:

Correction: November 9, 2012

An earlier version of this article incorrectly stated that David H. Petraeus was expected to remain in President Obama’s cabinet. The C.I.A. director is not a cabinet member in the Obama administration.



Read More..

Jimmy Kimmel’s Family Members Are Apparently Fair Game
















We realize there’s only so much time one can spend in a day watching new trailers, viral video clips, and shaky cell phone footage of people arguing on live television. This is why every day The Atlantic Wire highlights the videos that truly earn your five minutes (or less) of attention. Today:


RELATED: The Roots Take on ‘Call Me Maybe’ (and Win)













Watch this video, bookmark it, and watch it the next time you think you’d rather go home than wait in a long line to vote. Seriously, Time‘s look at the Rockaways on the election night hits the matrix where heart-break and optimism meet and it makes you really appreciate a right we shouldn’t take for granted: 


RELATED: Cookie Monster Batman and the Dog You Wish You Had


RELATED: Behold the Power of ‘Gangnam Style’


The best part of Louis C.K.’s SNL appearance was his “Lincoln” skit. Six days later, here we are with a new video: the director’s cut of the Lincoln-Louie parody—it’s funnier, dirtier, and one really awesome look at what NBC think is too offensive for network television. 


RELATED: The Robot That Performs Gangnam Style Better Than You


RELATED: The Uncle You Wish You Had and the Joy of Human Jukeboxes


Children, we’ve learned, are not safe from the pranks of Jimmy Kimmel. Neither is Jimmy Kimmel‘s aunt. 


And finally, the weekend is here. We’re talking like one hour away. This baby elephant video is clear evidence of that: 


Wireless News Headlines – Yahoo! News



Read More..

Philip Roth says he's done writing

NEW YORK (AP) — Exit, Philip Roth? Having conceived everything from turning into a breast to a polio epidemic in his native New Jersey, Roth has apparently given his imagination a rest.

The 79-year-old novelist recently told a French publication, Les inRocks, that his 2010 release "Nemesis" would be his last. Spokeswoman Lori Glazer of Houghton Mifflin Harcourt said Friday that she had spoken with Roth and that he confirmed his remarks. Roth's literary agent, Andrew Wylie, declined comment.

Roth certainly produced, completing more than 20 novels over half a century and often turning out one a year. He won virtually every prize short of the Nobel and wrote such classics as "American Pastoral" and "Portnoy's Complaint."

His name will remain on new releases, if only because the Library of America has been issuing hardcover volumes of his work. Roth also is cooperating with award-winning biographer Blake Bailey on a book about his life.

The author chose an unexpected forum to break the news, but he has been hinting at his departure for years. He has said that he no longer reads fiction and seemed to say goodbye to his fictional alterego, Nathan Zuckerman, in the 2007 novel "Exit Ghost."

Retirement is rarely the preferred option for writers, for whom the ability to tell stories or at least set down words is often synonymous with life itself. Poor health, discouragement and even madness are the more likely ways literary careers end. Roth apparently is fit and his recent novels had been received respectfully, if not with the awe of his most celebrated work.

"I don't believe it," Roth's friend and fellow writer Cynthia Ozick said upon learning the news. "A writer who stops writing while still breathing has already declared herself posthumous."

His parting words from "Nemesis": "He seemed to us invincible."

Roth's interview appeared in French and has been translated, roughly, by The Associated Press. He tells Les inRocks that "Nemesis" was "mon dernier livre" ("My last book") and refers to "Howard's End" author E.M. Forster, and how he quit fiction in his 40s. Roth said he doesn't plan to write a memoir, but will instead go through his archives and help ensure that Bailey's biography comes out in his lifetime.

Explaining why he stopped, Roth said that at age 74 he became aware his time was limited and that he started re-reading his books of the past 20-30 years, in reverse order. He decided that he agreed with what the boxer Joe Louis had said late in life, that he had done the best he could with what he had.

Read More..

Malaria Vaccine Candidate Produces Disappointing Results in Clinical Trial


The latest clinical trial of the world’s leading malaria vaccine candidate produced disappointing results on Friday. The infants it was given to had only about a third fewer infections than a control group.


But researchers said they wanted to press on, assuming they keep getting financial support, because the number of children who die of malaria is so great that even an inefficient vaccine can save thousands of lives.


Three shots of the vaccine, known as RTS, S or Mosquirix and produced by GlaxoSmithKline, gave babies fewer than 12 weeks old 31 percent protection against detectable malaria and 37 percent protection against severe malaria, according to an announcement by the company at a vaccines conference in Cape Town.


Last year, in a trial in children up to 17 months old, the same vaccine gave 55 percent protection against detectable malaria and 47 percent against severe malaria.


The new trial “is less than we’d hoped for,” Moncef Slaoui, chairman of research and development at Glaxo, said in a telephone interview. “But if a million babies were vaccinated, we would prevent 260,000 cases of malaria a year. This is a disease that kills 655,000 babies a year — 31 percent of that is a very large number.”


The company, which has already spent more than $300 million on the vaccine, wants to keep forging ahead, Mr. Slaoui said, “but it is not just our decision.”


It also depends on the PATH Malaria Vaccine Initiative, which has put more than $200 million of its Bill and Melinda Gates Foundation financing into the vaccine, and on the World Health Organization, which has helped talk seven African countries into allowing the vaccine to be tested on their children.


The Gates Foundation declined to say how much money it was ultimately prepared to spend on an imperfect vaccine; this set of trials is set to go into 2014.


“The efficacy came back lower than we had hoped, but developing a vaccine against a parasite is a very hard thing to do,” Bill Gates said in a prepared statement. “The trial is continuing, and we look forward to getting more data to help determine whether and how to deploy this vaccine.”


All the families in the trial were given insecticide-treated mosquito nets and encouraged to use them; 86 percent did, so the vaccine worked despite other anti-malaria measures.


RTS, S contains a protein found on the parasite’s surface that provokes an immune reaction. It was first identified decades ago by two New York University scientists, Ruth and Victor Nussenzweig. The vaccine was developed by Glaxo in Belgium and initially tested on American volunteers by the Walter Reed Army Institute of Research.


When the Gates Foundation began focusing on global health in the early part of this century, it was one of the first projects the foundation adopted. Different ways to make the vaccine more effective, including adding different boosters and giving more shots, are being experimented with. Other vaccines using different ways to provoke an immune reaction exist, but none are as far along in clinical trials.


Like an H.I.V. vaccine, one against malaria has proved an elusive goal. The parasite morphs several times, exhibiting different surface proteins as it goes from mosquito saliva into blood and then into and out of the liver. Also, even the best natural “vaccine” — catching the disease itself — is not very effective. While one bout of measles immunizes a child for life, it usually takes several bouts of malaria to confer even partial immunity. Pregnancy can cause women to stop being immune, and immunity can fade out if someone moves away from a malarial area — presumably because they no longer get “boosters” from repeated mosquito bites.


Read More..

Common Sense: At Martha Stewart Living, Martha May Be the Problem


Among America’s corporate leaders, there are surely few whose interests are more closely aligned with their shareholders’ than the homemaking icon Martha Stewart. She owns 26 million shares and controls nearly 90 percent of the voting rights of Martha Stewart Living Omnimedia. She’s the company’s nonexecutive chairwoman and serves on the board. Martha Stewart, the company, is inseparable from Martha Stewart, the person.


Her net worth is inextricably tied to the value of the shares. That would seem obvious to everyone except, perhaps, Ms. Stewart herself. She continues to collect lavish multimillion-dollar compensation and perks while her company teeters under the weight of huge losses, its shares trading for a fraction of their former value. The paradox is that if the stock had risen even $1 a share in recent years, Martha Stewart would be wealthier now than if she had taken only nominal compensation from the company.


“You’d think there’d be very little need for board oversight because of the strong alignment of the company’s interests with her personal wealth,” Paul Hodgson, a compensation expert and senior research associate at GMI Ratings, told me this week. “Everything should be pushing her to make sure the company succeeds. For some reason, that’s not happening.”


Last week, Ms. Stewart’s company reported a $50.7 million quarterly loss, a staggering amount considering it exceeded total revenue, which was just $43.5 million. That was a 17 percent drop from revenue in the same quarter last year. Although the loss included a $44.3 million noncash write-down related to the shrinking value of two of its magazines, the company until recently has been bleeding cash, which dropped from $38.5 million to just $17.4 million in the quarter. The company said it would lay off about 70 employees, 12 percent of its work force, and discontinue its stand-alone print version of the magazine Everyday Food.


None of this bad news has made much of a dent on Ms. Stewart’s own compensation. Her base annual pay rose from $1.7 million in 2009 to $2 million in 2010 and 2011, and she received a $3 million retention bonus when she signed her new contract in 2009. She gets an additional minimum of $2 million a year under an “intangible assets license agreement,” which gives the company the rights to “Martha Stewart’s lifestyle and the public perception of Martha Stewart’s lifestyle,” including such details as how she arranges her outdoor furniture.


Her corporate perks are well known, and she has long blurred the line between business and personal expenses. She submitted as a business expense the $17,000 cost of her now-infamous holiday trip to the Mexican luxury resort Las Ventanas al Paraiso. She arrived at the resort the day she dumped her shares in the biotechnology company ImClone upon learning, en route, that the company’s chief executive was trying to sell his shares ahead of a negative Food and Drug Administration decision on the company’s principal drug. (She settled charges of insider trading brought by the Securities and Exchange Commission after being convicted of making criminal false statements to cover up the reason for the sale.) Then she had her accountant tell her companion on the trip that she’d have to pay her “fair share” of the costs, according to testimony in her 2004 trial.


The company doesn’t break out Ms. Stewart’s reimbursed expenses, but general and administrative expenses amounted to a lofty $11 million in the last quarter. That number, of course, includes many expenses besides Ms. Stewart’s, like other executives’ salaries.


The company does reveal what it calls other compensation for Ms. Stewart, which in 2011 included a personal trainer and other expenses for personal fitness; a weekend driver; security services; fees for on-air appearances; unspecified personnel costs not otherwise reimbursed by the company; insurance premiums; and an unidentified charitable contribution, which added up to over $1 million.


Ms. Stewart also receives stock options, nearly $1.8 million worth in 2009 through 2011, though she has not received any options so far this year. Still, as Mr. Hodgson put it, “Why is she even getting stock options? Her interests are already thoroughly aligned with the company, given her ownership stake.” Moreover, the intangible license agreement “is very unusual,” Mr. Hodgson said.


All told, Ms. Stewart’s compensation was $9.8 million in 2009, $5.9 million in 2010 and $5.5 million in 2011, or $21.2 million over the last three years, even as the company was in a downward spiral. Just before Ms. Stewart got out of prison in 2005, her shares were trading at over $34 and she was a billionaire. After plunging during the financial crisis, they were above $8 a share in September 2009. They traded this week at about $2.80.


Asked about the issues raised in this column, a spokesman for Martha Stewart Living Omnimedia declined to comment and said Ms. Stewart had no comment.


Read More..

Pentagon Says Iran Fired at Surveillance Drone Last Week





WASHINGTON — Iranian warplanes fired at an unmanned American military surveillance drone in international airspace over the Persian Gulf last week, Pentagon officials disclosed Thursday, saying that while the aircraft was not hit, Washington made a strong protest to Tehran.




The shooting, which the Pentagon said occurred Nov. 1 — five days before the American presidential election — was the first known instance of Iranian warplanes firing on an American surveillance drone.


George Little, the top Pentagon spokesman, attributed the weeklong silence on the incident to restrictions on discussing classified surveillance missions. But it doubtless will raise questions about whether that silence had been meant to forestall an international controversy before the election. Had a decision been made to officially disclose the shooting, it might have been viewed as a provocative or even partisan political act before the voting.


Mr. Little discussed the episode during a Pentagon news conference only after the shooting had been disclosed by news organizations.


A senior administration official sought to tamp down the ripple effects of the episode, noting that it should not be viewed as a precursor to a broader military confrontation or as something that would derail potential diplomatic contacts between the United States and Iran over its disputed nuclear program. “We view it as another data point in what is clearly more aggressive tactics on the part of the Iranians,” the senior official said. “That said, it’s another data in which they were wildly unsuccessful.”


Word of the firing on the drone came against a backdrop of severe tensions between the United States and Iran, principally over the nuclear program, which has led to heavy sanctions on Iran that have deeply afflicted the country’s economy — most notably its ability to do international financial transactions and to sell oil, the most important Iranian export. Further sanctions were announced on Thursday by Treasury and State Department officials.


At the same time, there has been some optimism that President Obama, elected to a second term, might have some new political leverage to negotiate with Iran over the nuclear program, which the Iranians sayd is meant for peaceful purposes. The United States and Israel have called the program a guise to create the ability to make nuclear weapons.


There was no immediate comment from Iran on the Pentagon disclosure about the drone.


Mr. Little said Iranian warplanes “fired multiple rounds” but missed the drone, a Predator, which has a unique silhouette similar to a giant, upside-down flying spoon, and it is not easily confused with a piloted jet fighter.


Officials declined to speculate about whether the Iranian pilots were trying to shoot down the drone or were simply firing warning shots. But one official briefed on the episode said the Iranian planes — identified as Soviet-made SU-25 jets known as Frogfoots — carry cannon for supporting ground troops and are not especially adept at air-to-air combat.


Mr. Little said the Predator was flying about 16 nautical miles from Iran while conducting a routine maritime surveillance mission. He stressed that Iran’s territorial limits extend 12 nautical miles from its shores, and that the drone never strayed into Iranian space.


Given the critical role of the Persian Gulf and the Strait of Hormuz in the international shipping of petroleum products, the American military conducts regular seaborne and aerial surveillance of those routes. Even so, the advanced sensor technology aboard the Predator is likely to have allowed it to get a detailed look at Iran even from the distance cited by Pentagon officials.


Mr. Little said a protest had been delivered to Iran via the Swiss Embassy in Tehran, which acts on behalf of American interests there, and that the Defense Department would not halt surveillance missions.


“The United States has communicated to the Iranians that we will continue to conduct surveillance flights over international waters, over the Arabian Gulf, consistent with longstanding practice and our commitment to the security of the region,” Mr. Little said, using a name for the Persian Gulf that the Iranians have long rejected.


He cautioned Iran that the United States had “a wide range of options, from diplomatic to military, to protect our military assets and our forces in the region and will do so when necessary.”


Late last year, a C.I.A. surveillance drone crashed deep inside Iranian territory while on a mission that was believed to be designed to map suspected nuclear sites. While some Iranian officials said the drone was shot down or guided to land safely through electronic intervention of its guidance system, American officials said it had crashed after a technical malfunction.


Assessing Iranian intentions has been difficult. American officials said the two Iranian warplanes involved in the episode were under command not of the air force, but of the Revolutionary Guard Corps, whose activities are routinely more brazen than those of the conventional Iran military.


Similarly, Iran has two navies: one, its traditional state navy of aging big ships dating from the era of the shah, and the other they olitically favored Revolutionary Guards navy of fast-attack speedboats and guerrilla tactics. Senior American naval officers say that the Iranian state navy is for the most part professional and predictable, but that the Revolutionary Guards navy, which has responsibility for the operations in the Persian Gulf, is not.


Thom Shanker reported from Washington, and Rick Gladstone from New York. Mark Landler contributed reporting from Washington.



Read More..

Exclusive: Google Ventures beefs up fund size to $300 million a year

SAN FRANCISCO (Reuters) - Google will increase the cash it allocates to its venture-capital arm to up to $300 million a year from $200 million, catapulting Google Ventures into the top echelon of corporate venture-capital funds.


Access to that sizeable checkbook means Google Ventures will be able to invest in more later-stage financing rounds, which tend to be in the tens of millions of dollars or more per investor.


It puts the firm on the same footing as more established corporate venture funds such as Intel's Intel Capital, which typically invests $300-$500 million a year.


"It puts a lot more wood behind the arrow if we need it," said Bill Maris, managing partner of Google Ventures.


Part of the rationale behind the increase is that Google Ventures is a relatively young firm, founded in 2009. Some of the companies it backed two or three years ago are now at later stages, potentially requiring larger cash infusions to grow further.


Google Ventures has taken an eclectic approach, investing in a broad spectrum of companies ranging from medicine to clean power to coupon companies.


Every year, it typically funds 40-50 "seed-stage" deals where it invests $250,000 or less in a company, and perhaps around 15 deals where it invests up to $10 million, Maris said. It aims to complete one or two deals annually in the $20-$50 million range, Maris said.


LACKING SUPERSTARS


Some of its investments include Nest, a smart-thermostat company; Foundation Medicine, which applies genomic analysis to cancer care; Relay Rides, a carsharing service; and smart-grid company Silver Spring Networks. Last year, its portfolio company HomeAway raised $216 million in an initial public offering.


Still, Google Ventures lacks superstar companies such as microblogging service Twitter or online bulletin-board company Pinterest. The firm's recent hiring of high-profile entrepreneur Kevin Rose as a partner could help attract higher-profile deals.


Soon it could have even more cash to play around with. "Larry has repeatedly asked me: 'What do you think you could do with a billion a year?'" said Maris, referring to Google chief executive Larry Page.


(Editing by Muralikumar Anantharaman)


Read More..

Marilyn Monroe photos on auction in Poland

WARSAW, Poland (AP) — Who doesn't want a picture of Marilyn Monroe?

Hundreds of photographs of the blonde bombshell and other celebrities, including famous ones of Monroe in bed and as a ballerina, were being sold Thursday evening at an auction house in Poland.

Bidders and spectators packed the Desa Unicum house in Warsaw, where 238 pictures by the late American fashion and celebrity photographer Milton H. Greene were up for sale.

Most of these pictures of Monroe were taken from 1953 to 1957 when Greene was her advisor and business partner. He made many of the prints during Monroe's lifetime and they are highly valued by collectors. They include series of refined black-and-white studio photos and shots taken in natural surroundings, sometime in provocative poses.

As the bidding began, a black-and-white photo of a reclining Monroe in black stockings sold for 50,000 zlotys ($16,000), and another of her in a ballerina's dress sold for almost $20,000. A picture of her in bed sold for 26,000 zlotys.

The auction also offered Greene's pictures of Audrey Hepburn, Grace Kelly, Marlene Dietrich and Liza Minnelli. Other greats in the vast portrait collection, which was estimated at $680,000, included Cary Grant, Frank Sinatra, Paul Newman, Alfred Hitchcock and Marlon Brando.

The photos come from a collection of some 4,000 Greene pictures that Poland obtained from Chicago businessman Dino Matingas in the mid-1990s as the result of a complex communist-era embezzlement scandal linked to the buy-out of Poland's state debt. Proceeds from the auction will go to the Polish government.

Some of the images have never been published before, according to Marta Maciazek, the Polish official in charge of cleaning up the mess from the corruption affair.

Read More..

Ask an Expert: Wondering About Alzheimer’s? Ask Here





This week’s Ask the Expert features Dr. P. Murali Doraiswamy, who will answer questions related to Alzheimer’s disease and memory loss. He is a professor of psychiatry at Duke University Medical Center and an author of “The Alzheimer’s Action Plan.” Dr. Doraiswamy has also served as an adviser to government agencies, advocacy groups and businesses.




About five million Americans today live with Alzheimer’s disease, and a new diagnosis is made about every 70 seconds. Cases are expected to triple over the coming decades as baby boomers age.


Misperceptions and misdiagnoses are common about Alzheimer’s, which ranks second to only cancer among diseases that adults fear the most. Many people do not understand that there are dozens of causes for memory loss besides Alzheimer’s, including many that can be fully reversed if caught early.


Among the questions Dr. Doraiswamy is prepared to answer:


What are the best tests to determine if it is or isn’t Alzheimer’s?


How do you determine your own risk?


What are the family-care options? Medications for memory? Medications for behavior problems? Preventive strategies?


What has been learned from the latest clinical trials?


How can you improve your memory?


Please leave your questions in the comments section. Answers will be posted on Wednesday.


You can follow Booming via RSS here or visit nytimes.com/booming.


Read More..

Popular Wrench Fights a Chinese Rival


John Gress for The New York Times


Dan Brown, inventor of the Bionic Wrench, is defending his patent rights against the Max Axess, made in China.







Last Christmas, Sears had a brisk seller in the Bionic Wrench, an award-winning, patented tool with spiffy lime green accents. This holiday season, though, Sears has a special display for its own wrench, in the red and black colors of its house brand, Craftsman.








William P. O'Donnell/The New Yortk Times

The Bionic Wrench is made in America by Penn United Technologies. Sears sells the Max Axess, sourced from China.






One customer who recently spotted the new Craftsman tool, called the Max Axess wrench, thought it was an obvious knockoff, right down to the try-me packaging. “I saw it and I said, ‘This is a Bionic Wrench,’ ” recalled Dana Craig, a retiree and tool enthusiast in Massachusetts who alerted the maker of the Bionic Wrench. “It’s a very distinctive tool,” he added.


The tools have one significant difference, Mr. Craig noted. The Bionic Wrench is made in the United States. The Max Axess wrench is made in China.


The shift at Sears from a tool invented and manufactured in the United States to a very similar one made offshore has already led to a loss of American jobs and a brewing patent battle.


The story of the Bionic Wrench versus Craftsman, which bills itself as “America’s most trusted tool brand,” also raises questions about how much entrepreneurs and innovators, who rely on the country’s intellectual property laws, can protect themselves. For the little guy, court battles are inevitably time-consuming and costly, no matter the outcome.


Still, the inventor of the Bionic Wrench is determined to fight. He is Dan Brown, an industrial designer in Chicago who came up with the wrench after watching his son try to work on a lawn mower. Mr. Brown says he believes that the Max Axess wrench copies his own and he is planning to file suit against Sears, which declined to answer any questions about the wrenches for this article.


The Bionic Wrench is distinguished by its gripping mechanism, a circle of metal prongs that, inspired by the shutter in a single-lens reflex camera, descend evenly to lock onto almost any nut or bolt.


Since Sears has halted new orders, the Pennsylvania company that makes the Bionic Wrench has had to lay off 31 workers, said Keith Hammer, the project manager at the company, Penn United Technologies. “And that’s not to mention our suppliers,” he added.


Mr. Brown sees a broader issue than just the fate of his wrench. “Our situation is an example of why we’re not getting jobs out of innovation,” he said. “When people get the innovation, they go right offshore. What happened to me is what happened to so many people so many times, and we just don’t talk about it.”


Inventors typically spend $10,000 to $50,000 to obtain the type of patent Mr. Brown has on the wrench, said John S. Pratt, a patent expert at Kilpatrick Townsend & Stockton in Atlanta. Though he said he could not comment on the merits of Mr. Brown’s potential suit, patent infringement cases can be especially difficult in the tool field, where many improvements are incremental, Mr. Pratt explained.


A defendant in such a case would most likely argue that either the tool did not warrant a patent in the first place, or that its own product did not violate the patent.


The fact that Sears made some changes to the wrench’s design, like making the grooves that allow the metal prongs to slide back and forth visible instead of hidden, will make the case more challenging, he said. “It’s hard for me to imagine that Sears isn’t particularly careful about breach of patent, so there’s probably another side to the story,” he said.


After patenting the wrench in 2005, Mr. Brown formed a company, LoggerHead Tools, to bring it to market, making a point of having it made in the United States.


The Bionic Wrench was greeted with enthusiasm at trade shows and in industrial design competitions, and the company survived the downturn in 2008. Mr. Brown resisted overtures from large chain stores that wanted to sell the tool under their proprietary brand, he said, and rejected the lure of cheaper manufacturing in China. “I was raised a different way,” he said.


The tool sold fairly well on its own — LoggerHead has shipped 1.75 million of them — but Mr. Brown, 56, who teaches industrial design at Northwestern University, says LoggerHead operated on a shoestring and he plowed much of the profit back into the company. “You cannot have big offices and fancy cars and everybody with an administrative assistant, because we are competing with China,” he said.


Read More..